Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Bifidobacterium Bifidum (Bf-688) on Clinical Characteristics and Gut Microbiota in Attention-deficit/Hyperactivity Disorder: a Double-blind Randomized-control Trial

NCT04958460 is registered in ClinicalTrials.gov with Wang Liang-Jen as lead sponsor.

NCT NCT04958460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04958460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Bifidobacterium Bifidum (Bf-688) on Clinical Characteristics and Gut Microbiota in Attention-deficit/Hyperactivity Disorder: a Double-blind Randomized-control Trial
Lead sponsor
Wang Liang-Jen
Phase
Phase 3
Overall status
Completed
Start date
May 14, 2020
Completion date
February 28, 2023
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, clinical trial, gut microbiota, probiotics, psychiatry